Medicinal products according to the National List under DK 021:2015: 33600000-6 Pharmaceutical products (Suxamethonium, solution for injection, 20 mg/ml, 5 ml per vial (INN: Suxamethonium; DK 021:2015: 33630000-5 Medicinal products for dermatological and musculoskeletal diseases)).

This tender seeks the supply of Suxamethonium, a solution for injection, specified as 20 mg/ml in 5 ml vials. The product falls under the National List of Essential Medicines and is categorized under CPV code 33630000-5 (Medicinal products for dermatological and musculoskeletal diseases), with a broader classification of Pharmaceutical products (CPV 33600000-6). A critical condition for participation is that the offered product must not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. By submitting a price proposal, participants confirm their compliance with this origin restriction. The procuring entity is the Communal Enterprise "Blyzniukivska Central District Hospital" of the Blyzniukivska settlement council, Lozivskyi district, Kharkiv region. This procurement is vital for the hospital's operations, ensuring the availability of essential anesthetic or muscle relaxant medication for patient treatment.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 5,500.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.